Home/Pipeline/AKG‑TB‑LAI

AKG‑TB‑LAI

Tuberculosis (multidrug‑resistant)

Phase 1Active

Key Facts

Indication
Tuberculosis (multidrug‑resistant)
Phase
Phase 1
Status
Active
Company

About Akagera Medicines

Rwanda‑based biotech delivering liposomal long‑acting injectables for TB and infectious disease vaccines.

View full company profile